Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3852 | 1895 | 39.0 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
566 | 2 | EPOXYEICOSATRIENOIC ACIDS//LIPOXYGENASE//LEUKOTRIENES | 14430 |
3852 | 1 | 5 LIPOXYGENASE//LEUKOTRIENES//5 LIPOXYGENASE ACTIVATING PROTEIN | 1895 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 5 LIPOXYGENASE | authKW | 1022961 | 12% | 28% | 223 |
2 | LEUKOTRIENES | authKW | 750425 | 15% | 16% | 293 |
3 | 5 LIPOXYGENASE ACTIVATING PROTEIN | authKW | 494289 | 2% | 65% | 47 |
4 | LEUKOTRIENE A4 HYDROLASE | authKW | 452240 | 2% | 70% | 40 |
5 | CHEM 2 | address | 327893 | 3% | 38% | 53 |
6 | BLT2 | authKW | 299359 | 1% | 77% | 24 |
7 | LEUKOTRIENE B 4 | authKW | 251140 | 5% | 15% | 101 |
8 | ALOX5AP | authKW | 200552 | 1% | 66% | 19 |
9 | LEUKOTRIENE A4 | authKW | 196404 | 1% | 76% | 16 |
10 | 5 LIPOXYGENASE ACTIVATING PROTEIN FLAP | authKW | 161119 | 1% | 100% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 4163 | 40% | 0% | 764 |
2 | Chemistry, Medicinal | 2111 | 11% | 0% | 199 |
3 | Cell Biology | 1258 | 15% | 0% | 281 |
4 | Biophysics | 1109 | 10% | 0% | 184 |
5 | Immunology | 1031 | 13% | 0% | 242 |
6 | Pharmacology & Pharmacy | 1021 | 16% | 0% | 298 |
7 | Medicine, Research & Experimental | 337 | 6% | 0% | 116 |
8 | Hematology | 309 | 5% | 0% | 89 |
9 | Endocrinology & Metabolism | 253 | 6% | 0% | 108 |
10 | Respiratory System | 224 | 3% | 0% | 65 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEM 2 | 327893 | 3% | 38% | 53 |
2 | PHYSIOL CHEM 2 | 141250 | 3% | 18% | 50 |
3 | CHAIR PHARMACEUT MED CHEM | 112755 | 1% | 33% | 21 |
4 | MED BIOCHEM BIOPHYS | 89265 | 7% | 4% | 135 |
5 | PHARMACEUT ANALYT | 72477 | 1% | 25% | 18 |
6 | PHARMACEUT CHEM ZAFES | 50183 | 0% | 35% | 9 |
7 | RECH INFLAMMAT IMMUNOL RHUMATOL | 42962 | 0% | 67% | 4 |
8 | CARDIOPULM PHARMACOL | 39534 | 0% | 27% | 9 |
9 | AFFILIATED CLIN 4 | 32224 | 0% | 100% | 2 |
10 | ARRHENIUS A4 | 32224 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 30868 | 2% | 5% | 39 |
2 | JOURNAL OF LIPID MEDIATORS | 17024 | 1% | 6% | 17 |
3 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 7017 | 2% | 1% | 37 |
4 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 5990 | 1% | 1% | 26 |
5 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 3712 | 1% | 1% | 25 |
6 | PROSTAGLANDINS | 2440 | 1% | 1% | 15 |
7 | JOURNAL OF MEDICINAL CHEMISTRY | 2106 | 3% | 0% | 54 |
8 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 1444 | 0% | 2% | 5 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1397 | 3% | 0% | 48 |
10 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1338 | 6% | 0% | 119 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 5 LIPOXYGENASE | 1022961 | 12% | 28% | 223 | Search 5+LIPOXYGENASE | Search 5+LIPOXYGENASE |
2 | LEUKOTRIENES | 750425 | 15% | 16% | 293 | Search LEUKOTRIENES | Search LEUKOTRIENES |
3 | 5 LIPOXYGENASE ACTIVATING PROTEIN | 494289 | 2% | 65% | 47 | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN |
4 | LEUKOTRIENE A4 HYDROLASE | 452240 | 2% | 70% | 40 | Search LEUKOTRIENE+A4+HYDROLASE | Search LEUKOTRIENE+A4+HYDROLASE |
5 | BLT2 | 299359 | 1% | 77% | 24 | Search BLT2 | Search BLT2 |
6 | LEUKOTRIENE B 4 | 251140 | 5% | 15% | 101 | Search LEUKOTRIENE+B+4 | Search LEUKOTRIENE+B+4 |
7 | ALOX5AP | 200552 | 1% | 66% | 19 | Search ALOX5AP | Search ALOX5AP |
8 | LEUKOTRIENE A4 | 196404 | 1% | 76% | 16 | Search LEUKOTRIENE+A4 | Search LEUKOTRIENE+A4 |
9 | 5 LIPOXYGENASE ACTIVATING PROTEIN FLAP | 161119 | 1% | 100% | 10 | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN+FLAP | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN+FLAP |
10 | LTA4 HYDROLASE | 128887 | 1% | 67% | 12 | Search LTA4+HYDROLASE | Search LTA4+HYDROLASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HAEGGSTROM, JZ , FUNK, CD , (2011) LIPOXYGENASE AND LEUKOTRIENE PATHWAYS: BIOCHEMISTRY, BIOLOGY, AND ROLES IN DISEASE.CHEMICAL REVIEWS. VOL. 111. ISSUE 10. P. 5866 -5898 | 221 | 50% | 196 |
2 | BACK, M , (2009) INHIBITORS OF THE 5-LIPOXYGENASE PATHWAY IN ATHEROSCLEROSIS.CURRENT PHARMACEUTICAL DESIGN. VOL. 15. ISSUE 27. P. 3116 -3132 | 121 | 65% | 19 |
3 | RADMARK, O , WERZ, O , STEINHILBER, D , SAMUELSSON, B , (2015) 5-LIPOXYGENASE, A KEY ENZYME FOR LEUKOTRIENE BIOSYNTHESIS IN HEALTH AND DISEASE.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1851. ISSUE 4. P. 331 -339 | 72 | 69% | 23 |
4 | RADMARK, O , SAMUELSSON, B , (2007) 5-LIPOXYGENASE: REGULATION AND POSSIBLE INVOLVEMENT IN ATHEROSCLEROSIS.PROSTAGLANDINS & OTHER LIPID MEDIATORS. VOL. 83. ISSUE 3. P. 162-174 | 87 | 81% | 51 |
5 | DI GENNARO, A , HAEGGSTROM, JZ , (2014) TARGETING LEUKOTRIENE B-4 IN INFLAMMATION.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 18. ISSUE 1. P. 79-93 | 85 | 72% | 8 |
6 | PETERS-GOLDEN, M , BROCK, TG , (2003) 5-LIPOXYGENASE AND FLAP.PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. VOL. 69. ISSUE 2-3. P. 99-109 | 90 | 78% | 118 |
7 | CALISKAN, B , BANOGLU, E , (2013) OVERVIEW OF RECENT DRUG DISCOVERY APPROACHES FOR NEW GENERATION LEUKOTRIENE A(4) HYDROLASE INHIBITORS.EXPERT OPINION ON DRUG DISCOVERY. VOL. 8. ISSUE 1. P. 49 -63 | 69 | 82% | 7 |
8 | DI GENNARO, A , HAEGGSTROM, JZ , (2012) THE LEUKOTRIENES: IMMUNE-MODULATING LIPID MEDIATORS OF DISEASE.ADVANCES IN IMMUNOLOGY, VOL 116. VOL. 116. ISSUE . P. 51-92 | 96 | 55% | 30 |
9 | RADMARK, O , (2002) ARACHIDONATE 5-LIPOXYGENASE.PROSTAGLANDINS & OTHER LIPID MEDIATORS. VOL. 68-9. ISSUE . P. 211-234 | 109 | 65% | 66 |
10 | HAEGGSTROM, JZ , WETTERHOLM, A , (2002) ENZYMES AND RECEPTORS IN THE LEUKOTRIENE CASCADE.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 59. ISSUE 5. P. 742 -753 | 92 | 72% | 52 |
Classes with closest relation at Level 1 |